Palvella Therapeutics Inc
(PVLA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 63,567 | 70,433 | 75,626 | 83,602 | 19,363 |
| Receivables | 2,216 | 1,978 | 1,978 | 2,336 | 879 |
| TOTAL | $66,937 | $73,747 | $79,439 | $88,234 | $20,522 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $66,937 | $73,747 | $79,439 | $88,234 | $20,522 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,481 | 4,557 | 4,441 | 4,586 | 801 |
| Accrued Expenses | 4,615 | 3,081 | 2,564 | 5,474 | 3,453 |
| Other current liabilities | 2,216 | 1,978 | 1,978 | 1,978 | N/A |
| TOTAL | $10,312 | $9,616 | $8,983 | $12,038 | $4,254 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 17,943 | 16,351 | 14,879 | 13,589 | 0 |
| TOTAL | $17,943 | $16,351 | $14,879 | $13,589 | $N/A |
| Total Liabilities | $28,255 | $25,967 | $23,862 | $25,627 | $4,254 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 11,836 | 11,060 | 11,056 | 11,019 | 1,320 |
| Common Shares | 11 | 11 | 11 | 11 | 1 |
| Retained earnings | -122,736 | -111,391 | -101,920 | -93,735 | -326,333 |
| Other shareholders' equity | 104 | -111 | -3 | 3 | -316 |
| TOTAL | $38,682 | $47,780 | $55,577 | $62,607 | $16,268 |
| Total Liabilities And Equity | $66,937 | $73,747 | $79,439 | $88,234 | $20,522 |